Announcements Trials
Browse Landscape

Phase

Phase 2 57Phase 3 44Phase 1/2 7Phase 1 5Phase 4 4Phase 2/3 4Phase NA 3Phase EARLY_PHASE1 1

Status

Completed 5Unknown 2

Sponsor Class

OTHER 7

Study Type

Interventional 7

Sponsor

Cancer Type

Plasma cell 7Genitourinary 2Gastrointestinal 2Other hematologic neoplasm 1Lymphoid 1Dermatologic 1

Conditions

Multiple Myeloma 6Plasmacytoma 1Neoplasms, Plasma Cell 1Immunoglobulin Light-chain Amyloidosis 1Amyloidosis 1

Interventions

Dexamethasone 140Lenalidomide 60Bortezomib 56Calcium Dobesilate 48Melphalan 44carfilzomib 40pomalidomide 39Cyclophosphamide 38daratumumab 27belantamab mafodotin 22ixazomib 19Peripheral Blood Stem Cell Transplantation 18fludarabine phosphate 16fludarabine 16dexamethasone acetate 14Bendamustine Hydrochloride 14Whole-Body Irradiation 13Filgrastim 13dexamethasone 21-phosphate 12Tacrolimus 12venetoclax 11auricularum 11Prednisone 11selinexor 10liposomal doxorubicin 10iberdomide 10Mycophenolic Acid 10isatuximab 9Cyclosporine 9pembrolizumab 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Phase 1/2 × Thalidomide × Plasma cell × Clear all
NCT04891744 2021-05-18

Selinexor in Combination With Thalidomide and Dexamethasone in RRMM

Sichuan University

Phase 1/2 Unknown
48 enrolled
Plasma cell

Multiple Myeloma

NCT02545907 2021-04-15

CATALYST

University College, London

Phase 1/2 Completed
10 enrolled 14 charts
Plasma cell

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

NCT00966693 2020-11-04

Lenalidomide, Thalidomide and Dexamethasone in Treating Participants With Relapsed or Refractory Multiple Myeloma

M.D. Anderson Cancer Center

Phase 1/2 Completed
77 enrolled 19 charts
Plasma cell

Multiple Myeloma

NCT01057225 2017-12-12

Cyclophosphamide, Carfilzomib, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Active Multiple Myeloma

Mayo Clinic

Phase 1/2 Completed
64 enrolled 13 charts
Plasma cell

Multiple Myeloma

NCT00406978 2016-05-10

MPTD

University of Turin, Italy

Phase 1/2 Completed
24 enrolled
Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

NCT02145715 2015-06-26

MUKsix

University of Leeds

Phase 1/2 Unknown
54 enrolled
Plasma cell

Multiple Myeloma

NCT00081757 2010-07-02

An Open Protocol for the Compassionate Use of Thalidomide

University of Arkansas

Phase 1/2 Completed
250 enrolled
Plasma cell

Multiple Myeloma, Plasmacytoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡